Consolidated Balance Sheets - USD ($) $ in Millions		Mar. 31, 2018	Dec. 31, 2017
ASSETS:
Cash and cash equivalents		$ 11.5	$ 8.2
Restricted cash and cash equivalents		368.5	255.6
Restricted securities available for sale	[1]	51.3	46.1
Loans receivable		5,498.1	5,049.0
Allowance for credit losses		(448.4)	(429.4)
Loans receivable, net		5,049.7	4,619.6
Property and equipment, net		20.4	20.5
Income taxes receivable		2.5	2.2
Other assets		30.1	33.4
Total Assets		5,534.0	4,985.6
Liabilities:
Accounts payable and accrued liabilities		168.9	151.7
Revolving secured line of credit		23.0	13.9
Secured financing		2,880.2	2,514.1
Senior notes		543.2	542.8
Deferred income taxes, net		206.4	187.4
Income taxes payable		55.6	39.9
Total Liabilities		3,877.3	3,449.8
Commitments and Contingencies - See Note 15
Shareholders' Equity:
Preferred stock, $0.01 par value, 1,000,000 shares authorized, none issued		0.0	0.0
Common stock, $0.01 par value, 80,000,000 shares authorized, 19,309,937 and 19,310,049 shares issued and outstanding as of March 31, 2018 and December 31, 2017, respectively		0.2	0.2
Paid-in capital		147.7	145.5
Retained earnings		1,509.3	1,390.3
Accumulated other comprehensive loss		(0.5)	(0.2)
Total Shareholders' Equity		1,656.7	1,535.8
Total Liabilities and Shareholders' Equity		$ 5,534.0	$ 4,985.6

[1] Measured and recorded at fair value on a recurring basis.